Lee A. Hebert

18.9k total citations · 1 hit paper
147 papers, 10.9k citations indexed

About

Lee A. Hebert is a scholar working on Nephrology, Rheumatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lee A. Hebert has authored 147 papers receiving a total of 10.9k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Nephrology, 38 papers in Rheumatology and 30 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lee A. Hebert's work include Renal Diseases and Glomerulopathies (48 papers), Systemic Lupus Erythematosus Research (35 papers) and Chronic Kidney Disease and Diabetes (32 papers). Lee A. Hebert is often cited by papers focused on Renal Diseases and Glomerulopathies (48 papers), Systemic Lupus Erythematosus Research (35 papers) and Chronic Kidney Disease and Diabetes (32 papers). Lee A. Hebert collaborates with scholars based in United States, China and Canada. Lee A. Hebert's co-authors include Brad H. Rovin, Tibor Nádasdy, Samir M. Parikh, Jason Prosek, Daniel J. Birmingham, Gyongyi Nadasdy, Anjali A. Satoskar, Sergey V. Brodsky, C. Yung Yu and Haikady N. Nagaraja and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Blood.

In The Last Decade

Lee A. Hebert

145 papers receiving 10.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach

2013 3.5k citations Lee A. Hebert, Tibor Nádasdy et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Lee A. Hebert	4.8k	2.6k	2.2k	1.9k	1.8k	147	10.9k
Tibor Nádasdy	3.7k 0.8×	1.7k 0.7×	1.3k 0.6×	1.2k 0.7×	1.7k 1.0×	175	9.0k
Claudio Ponticelli	7.7k 1.6×	3.2k 1.2×	2.0k 0.9×	1.5k 0.8×	2.8k 1.6×	464	16.4k
Hitoshi Yokoyama	4.6k 1.0×	1.1k 0.4×	1.5k 0.7×	2.2k 1.2×	2.0k 1.1×	268	11.4k
Kar Neng Lai	5.9k 1.2×	1.7k 0.7×	2.1k 1.0×	593 0.3×	1.5k 0.8×	354	12.9k
Francesco Paolo Schena	5.5k 1.2×	907 0.3×	2.3k 1.0×	1.1k 0.6×	1.5k 0.9×	279	14.1k
Richard J. Glassock	7.9k 1.7×	970 0.4×	1.4k 0.6×	1.2k 0.6×	2.5k 1.4×	261	12.8k
Jérôme Rossert	4.6k 1.0×	758 0.3×	1.1k 0.5×	1.4k 0.8×	1.5k 0.8×	107	11.4k
Samir M. Parikh	3.1k 0.7×	1.1k 0.4×	1.2k 0.5×	1.6k 0.8×	1.6k 0.9×	127	10.6k
Edmund J. Lewis	9.0k 1.9×	2.6k 1.0×	1.6k 0.7×	7.8k 4.1×	2.4k 1.3×	163	18.3k
Yasuhiko Tomino	11.0k 2.3×	1.6k 0.6×	2.9k 1.3×	2.8k 1.5×	2.5k 1.4×	626	19.7k

Countries citing papers authored by Lee A. Hebert

Since Specialization

Citations

This map shows the geographic impact of Lee A. Hebert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee A. Hebert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee A. Hebert more than expected).

Fields of papers citing papers by Lee A. Hebert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lee A. Hebert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee A. Hebert. The network helps show where Lee A. Hebert may publish in the future.

Co-authorship network of co-authors of Lee A. Hebert

This figure shows the co-authorship network connecting the top 25 collaborators of Lee A. Hebert. A scholar is included among the top collaborators of Lee A. Hebert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lee A. Hebert. Lee A. Hebert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ware, Kyle, Douglas L. Feinstein, Israel Rubinstein, et al.. (2017). The Severity of Intracranial Hemorrhages Measured by Free Hemoglobin in the Brain Depends on the Anticoagulant Class: Experimental Data. Stroke Research and Treatment. 2017. 1–4. 1 indexed citations

Lintner, Katherine E., Yee Ling Wu, Yan Yang, et al.. (2016). Early Components of the Complement Classical Activation Pathway in Human Systemic Autoimmune Diseases. Frontiers in Immunology. 7. 36–36. 128 indexed citations

Huang, Cheng, Amy Lehman, Alia Albawardi, et al.. (2013). IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression. Modern Pathology. 26(6). 799–805. 125 indexed citations

Ryan, Margaret, Kyle Ware, Zahida Qamri, et al.. (2013). Warfarin-related nephropathy is the tip of the iceberg: direct thrombin inhibitor dabigatran induces glomerular hemorrhage with acute kidney injury in rats. Nephrology Dialysis Transplantation. 29(12). 2228–2234. 82 indexed citations

Brodsky, Sergey V., Tibor Nádasdy, Brad H. Rovin, et al.. (2011). Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate. Kidney International. 80(2). 181–189. 223 indexed citations

Rovin, Brad H. & Lee A. Hebert. (2008). Response to ‘Aren't we forgetting ACE inhibitor's dark side’?. Kidney International. 74(6). 825–825. 1 indexed citations

Wu, Yee Ling, Stephanie Savelli, Yan Yang, et al.. (2007). Sensitive and Specific Real-Time Polymerase Chain Reaction Assays to Accurately Determine Copy Number Variations (CNVs) of Human Complement C4A , C4B , C4-Long , C4-Short , and RCCX Modules: Elucidation of C4 CNVs in 50 Consanguineous Subjects with Defined HLA Genotypes. The Journal of Immunology. 179(5). 3012–3025. 67 indexed citations

Birmingham, Dan, Brad H. Rovin, Ganesh Shidham, et al.. (2007). Spot urine protein/creatinine ratios are unreliable estimates of 24 h proteinuria in most systemic lupus erythematosus nephritis flares. Kidney International. 72(7). 865–870. 37 indexed citations

Rovin, Brad H. & Lee A. Hebert. (2007). Thiazide diuretic monotherapy for hypertension: Diuretic's dark side just got darker. Kidney International. 72(12). 1423–1426. 8 indexed citations

10.

Shidham, Ganesh & Lee A. Hebert. (2005). Timed Urine Collections Are Not Needed to Measure Urine Protein Excretion in Clinical Practice. American Journal of Kidney Diseases. 47(1). 8–14. 37 indexed citations

11.

Pesavento, Todd E., et al.. (2004). Mycophenolate therapy in frequently relapsing minimal change disease that has failed cyclophosphamide therapy. American Journal of Kidney Diseases. 43(3). e10.1–e10.4. 15 indexed citations

12.

Rovin, Brad H., Huijuan Song, Dan Birmingham, et al.. (2004). Urine Chemokines as Biomarkers of Human Systemic Lupus Erythematosus Activity. Journal of the American Society of Nephrology. 16(2). 467–473. 225 indexed citations

13.

Yang, Yan, Erwin K. Chung, Bi Zhou, et al.. (2003). The Intricate Role of Complement Component C4 in Human Systemic Lupus Erythematosus. PubMed. 7. 98–132. 97 indexed citations

14.

Cattran, Daniel, Gerald B. Appel, Lee A. Hebert, et al.. (2001). Cyclosporine in patients with steroid-resistant membranous nephropathy: A randomized trial. Kidney International. 59(4). 1484–1490. 249 indexed citations

15.

Birmingham, Daniel J., Brad H. Rovin, C. Yung Yu, & Lee A. Hebert. (2001). Of Mice and Men: The Relevance of the Mouse to the Study of Human SLE. Immunologic Research. 24(2). 211–224. 12 indexed citations

16.

Bakris, George L., DeJuran Richardson, İmke Janssen, et al.. (2000). ACE inhibition or angiotensin receptor blockade: Impact on potassium in renal failure. Kidney International. 58(5). 2084–2092. 9 indexed citations

17.

Hebert, Lee A., Garima Agarwal, Daniel D. Sedmak, et al.. (2000). Proximal tubular epithelial hyperplasia in patients with chronic glomerular proteinuria. Kidney International. 57(5). 1962–1967. 26 indexed citations

18.

Hebert, Lee A.. (1999). Target blood pressure for antihypertensive therapy in patients with proteinuric renal disease. Current Hypertension Reports. 1(5). 454–460. 4 indexed citations

19.

Hebert, Lee A. & William H. Bay. (1990). On the Natural Tendency to Progressive Loss of Remaining Kidney Function in Patients with Impaired Renal Function. Medical Clinics of North America. 74(4). 1011–1024. 5 indexed citations

20.

Hebert, Lee A.. (1987). Atlas of Glomerular Disease. The Journal of Urology. 137(3). 596–597. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact